重视危险比率:我们能否定义因果估计时间依赖的治疗效果?
1Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
Biometrical journal. Biometrische Zeitschrift
|November 29, 2025
概括
危险比为基线人群提供因果关系,但对于 t 时间处于危险状态的人群而不是.为了随时间进行有意义的治疗效应分析,需要新的因果关系估计.
科学领域:
- 生物统计学 生物统计学
- 流行病学 流行病学
- 因果推理因果推理
背景情况:
- 在因果推理中解释危险比率是复杂的.
- 在生存分析中理解因果关系需要仔细考虑时间依赖的种群.
研究的目的:
- 重新审视和澄清危险对比的因果解释.
- 调查危险比率代表因果关系的条件.
- 在生存分析中探索因果治疗效应的替代估计.
主要方法:
- 作为因果关系的危险比率的理论研究.
- 分析与相应和分离的生存曲线的场景.
- 检查常规和因果危险比率.
主要成果:
- 在时间t时的危险比为基线人群的因果关系,但对于时间t时面临风险的人群来说并不一般.
- 调查特定的生存曲线场景,可以了解危险比率的解释.
- 没有进一步的假设,在时间t > 0时对治疗效果的有意义的估计通常是缺乏的.
结论:
- 传统危险比率的因果解释是细微的,并且取决于人口.
- 该研究强调了使用标准方法在特定时间点估计治疗因果效应的局限性.
- 建议开发基于关于反事实生存时间的合理假设的替代估计.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
15.0K
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
1.1K
相关概念视频
Comparing the Survival Analysis of Two or More Groups
538
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
538
Hazard Ratio
549
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
549
Hazard Rate
380
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
380
Introduction To Survival Analysis
714
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
714
Assumptions of Survival Analysis
385
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
385
Kaplan-Meier Approach
537
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
537
